Work has now begun on another new technique in search of vaccines to relieve the coronavirus. For the first time in the country, the search has been completed on protein nano particle-based vaccines.
Pune-based Serum Institute of India has sought government approval for human testing of this vaccine, along with Oxford University and AstraZeneca's KovidShield, SII will now also test the protein nanoparticle vaccine.
Sources in the Union Health Ministry say SII has recently applied for it. Currently, Phase III trials on this technology are conducted in Europe. But will start after getting permission in India.
At the same time, in the special group meeting held on 17 December, this new application was reviewed in which the group decided that the placebo arm would also have to be included in the test. Also, the design of the second and third phases will have to be changed in the design. In addition, the group has asked for second stage test results b.
Eight types of vaccines can be found by March
According to a senior official of the special group formed about vaccines, an attempt is being made to break the protein structure of the virus in a way through this technique. Doing this can help in neutralizing the virus.
He said that if everything started on time, at least seven to eight types of vaccines could be available in India by March 2021. This will also affect the prices of vaccines. He said that in view of the country's large population, it is necessary to have more and more vaccines available.
Kovishield will be the first vaccine
Corona's first vaccine will remain in India by the Serum Institute of India. Vellore-based CMC senior doctor and vaccine expert Dr. Gagandeep Kang said that so far the government has received three different applications. But all the data has been made available on behalf of the serum.
He said that if we talk on the basis of the documents, by the end of this year India can get the first vaccine. The vaccine may be covishield prepared by Oxford University and AstraZeneca Company.